Registration, quality assurance and the shape of a medicines contract
A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programmes -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.
Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.
The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and programme funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.
This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.
Who buys pharmaceuticals in Ghana?
GlobalGov holds 238 pharmaceuticals records from 36 distinct buying organisations in Ghana. The most frequent publishers are Asamankese Government Hospital (57 records); Kibi Government Hospital (35 records); KIBI Government Hospital (20 records); Ejura Government Hospital (16 records); Bekwai Municipal Hospital (14 records); Ejura Government Hospital (7 records). Between them the 6 largest account for 63% of everything published, so buying here is concentrated in a few authorities.
| Buying organisation | Records | Share |
|---|---|---|
| Asamankese Government Hospital | 57 | 24% |
| Kibi Government Hospital | 35 | 15% |
| KIBI Government Hospital | 20 | 8.4% |
| Ejura Government Hospital | 16 | 6.7% |
| Bekwai Municipal Hospital | 14 | 5.9% |
| Ejura Government Hospital | 7 | 2.9% |
What are pharmaceuticals contracts worth in Ghana?
50 of the 238 records publish a contract value. The median is $563,150 and the largest single published value is $4.1M. By size, 5 under $100k, 33 between $100k and $1M, 12 between $1M and $10M. The remaining 188 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.
| Contract size | Records | Share of priced |
|---|---|---|
| under $100k | 5 | 10% |
| between $100k and $1M | 33 | 66% |
| between $1M and $10M | 12 | 24% |
| above $10M | 0 | 0.0% |
How long do bidders get to respond to pharmaceuticals tenders in Ghana?
Across the 71 Ghana pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 11 days. A quarter of them allowed 4 days or fewer and a quarter stayed open for more than 19. 42 of them (59%) closed within a fortnight of being published, so on this market a bidder who reviews notices once a week can lose most of the response window before reading one.
How often are pharmaceuticals tenders published in Ghana?
Ghana publishes about 8 notices a month in this category, 99 in the last twelve months. That is 43% more than the 69 published in the twelve months before that. Over the last three years there were 191, spread across 43 separate months of activity since 29 June 2021. March is historically the busiest month. The most recent was published 4 September 2026.
How does Ghana compare with other pharmaceuticals markets?
Among the 39 countries where GlobalGov holds a comparable pharmaceuticals market, Ghana ranks 23rd by number of records. The largest is Germany (4,115 records against 238 here). Within Ghana itself, pharmaceuticals is the 7th largest of the 34 procurement categories tracked here.
Where do the Ghana pharmaceuticals records on this page come from?
These 238 records are collected from 2 official sources: the Ghana Public Procurement Authority (236), UN Global Marketplace (2). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-10-01.
Most recent Pharmaceuticals tenders in Ghana
None of these are open for bids now — they are the most recent records GlobalGov holds for this market, kept here so the shape of a typical pharmaceuticals notice in Ghana is visible. Set an alert to be told when the next one opens.
Other procurement categories in Ghana
Pharmaceuticals procurement in other markets
Never Miss a Ghana Government Contract
Finding Ghana tenders usually means a local portal, a local registration and someone who reads the language. Get an alert you can read when a new pharmaceuticals opportunity is published there.
Start Free Trial